Department of Gynecologic Oncology and Obstetrics, Centre of Postgraduate Medical Education, Czerniakowska 231, 00-416, Warsaw, Poland.
Department of Genetics, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957, Warsaw, Poland.
J Hum Genet. 2020 Oct;65(10):889-894. doi: 10.1038/s10038-020-0784-0. Epub 2020 Jun 1.
Triploidy is a genetic aberration resulting from an extra haploid set of chromosomes of paternal (diandric) or maternal (digynic) origin. Diandric cases, opposite to digynic ones, may lead to gestational trophoblastic neoplasia (GTN) or generate maternal complications, therefore their identification is crucial, but reproducibility of traditionally used histopathological assessment is poor. The aim of the study was to analyse the usefulness of methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) with probes for two differentially methylated regions (DMR) at chromosome 11p.15.5 for identification of the parental origin of triploidy. 84 triploid DNA samples were tested with MS-MLPA: 34 paternal cases (40.5%) and 50 maternal ones (59.5%) according to the reference results of QF-PCR. Methylation ratio (MR) was calculated. Reference values proposed by the MRC-Holland for diploid samples (MR 0.8-1.2) were used. The values outside these ranges were used to diagnose parental origin of triploidy-paternal (MR > 1.2) or maternal (MR < 0.8). The effectiveness of MS-MLPA was 94.0%. The mean MR in paternal triploidy was 1.7 (SD-0.25; n = 34) compared with 0.56 in maternal triploidy (SD-0.12; n = 50). MR values in paternal and maternal triploidy did not overlap. In five samples (6.0%) parental origin of triploidy could not be accurately established by MS-MLPA, probably due to the maternal cell contamination (MCC). MS-MLPA can be used as a convenient method for distinguishing between paternal and maternal triploidy without the necessity for parental samples testing. It enables adequate selection of the paternal triploid cases for follow up in order to exclude post-molar GTN.
三倍体是一种遗传异常,由来自父本(二倍体)或母本(二倍体)的额外一套单倍体染色体引起。与二倍体病例相反,二倍体病例可能导致妊娠滋养细胞肿瘤(GTN)或引起母体并发症,因此识别它们至关重要,但传统使用的组织病理学评估的重现性较差。本研究旨在分析使用针对 11p.15.5 染色体上两个差异甲基化区域(DMR)的甲基化特异性多重连接依赖性探针扩增(MS-MLPA)鉴定三倍体的亲本来源的有用性。用 MS-MLPA 检测了 84 个三倍体 DNA 样本:根据 QF-PCR 的参考结果,34 个为父本病例(40.5%),50 个为母本病例(59.5%)。计算了甲基化比(MR)。使用 MRC-Holland 为二倍体样本提出的参考值(MR 0.8-1.2)。超出这些范围的值用于诊断三倍体的亲本来源-父本(MR>1.2)或母本(MR<0.8)。MS-MLPA 的有效性为 94.0%。父本三倍体的平均 MR 为 1.7(SD-0.25;n=34),而母本三倍体的平均 MR 为 0.56(SD-0.12;n=50)。父本和母本三倍体的 MR 值没有重叠。在五个样本(6.0%)中,MS-MLPA 无法准确确定三倍体的亲本来源,可能是由于存在母体细胞污染(MCC)。MS-MLPA 可用作区分父本和母本三倍体的便捷方法,无需检测亲本样本。它可以选择合适的父本三倍体病例进行随访,以排除摩尔后 GTN。